Donanemab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Donanemab and local guidelines before prescribing.

Anti-amyloid antibody

Mechanism

Anti-amyloid beta monoclonal antibody.

Uses

Early Alzheimer disease (specialist, restricted).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

ARIA (brain oedema or microhaemorrhage), infusion reactions, headache.

Interactions

Anticoagulants increase ARIA haemorrhage risk.

Contraindications and cautions

Anticoagulation, MRI abnormalities

Monitoring

MRI, neurology

Pregnancy and breastfeeding

Not applicable

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

MRI monitoring; APOE e4 homozygotes at higher risk.

More from the textbook: uses, cautions and other points
Where it is discussed in the book